Tilray Brands (NASDAQ: TLRY) reported third-quarter fiscal 2025 financial results Tuesday showing reduced cannabis sales and lowered forecasts, triggering a swift investor reaction.
Shares were down 6.56% to $0.54 in morning trading as investors responded to both the significant losses and downward revisions to future revenue projections.
Cannabis sales declined during the…
Please login to read all 462 words.